Dry eye Pipeline Highlights - 2017 - Research and Markets

Loading...
Loading...
DUBLIN--(BUSINESS WIRE)--

Research and Markets has announced the addition of the "Dry eye Pipeline Highlights - 2017" drug pipelines to their offering.

This report, Dry eye Pipeline Highlights - 2017, provides most up-to-date information on key pipeline products in the global Dry eye market. It covers emerging therapies for Dry eye in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Dry eye pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Dry eye pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Dry eye pipeline products by the company.

Short-term Launch Highlights:

Find out which Dry eye pipeline products will be launched in the US and Ex-US till 2020.

Summary:

  • Dry eye phase 3 clinical trial pipeline products
  • Dry eye phase 2 clinical trial pipeline products
  • Dry eye phase 1 clinical trial pipeline products
  • Dry eye preclinical research pipeline products
  • Dry eye discovery stage pipeline products
  • Dry eye pipeline products short-term launch highlights

Key Topics Covered:

1. Dry eye Pipeline by Stages

2. Dry eye Pipeline by Drug Class

3. Dry eye Pipeline by Company

4. Dry eye Phase 3 Clinical Trial Insights

5. Dry eye Phase 2 Clinical Trial Insights

6. Dry eye Phase 1 Clinical Trial Insights

7. Dry eye Preclinical Research Insights

8. Dry eye Discovery Stage Insights

9. Appendix

10. Research Methodology

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/vf2gmb/dry_eye_pipeline

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Optical, Optical Disorders Drugs

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...